Merck | MRK - Selling And Administration Expenses

Stock Price
107.80
Daily Change
-1.65 -1.51%
Monthly
-14.58%
Yearly
-20.76%
Q1 Forecast
104.71

Merck reported EUR1.6B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Adidas EUR 2.97B 225M Dec/2025
Adyen EUR 141.68M 211.99M Jun/2025
Akzo Nobel EUR 811M 28M Dec/2025
Alcon AG USD 901M 36M Dec/2025
Amadeus IT EUR 497.5M 206.6M Mar/2025
Amarin USD 17.94M 17.86M Sep/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
BASF EUR 2.21B 13M Dec/2025
Bayer EUR 4.05B 647M Dec/2025
Beiersdorf EUR 271M 51M Dec/2025
Covestro EUR 445M 8M Dec/2025
Danone EUR 4.87B 141M Jun/2025
Fresenius EUR 819M 143M Dec/2025
Fresenius Medical Care EUR 785M 79.56M Dec/2025
Galapagos EUR 44.42M 9.87M Dec/2025
Genmab DKK 144M 18M Jun/2025
Givaudan CHF 294.5M 229.5M Jun/2024
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GRIFOLS EUR 275.3M 9.7M Dec/2025
Henkel EUR 3.49B 38M Dec/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Infineon EUR 409M 8M Dec/2025
Linde USD 840M 30M Sep/2025
Merck EUR 1.6B 136M Dec/2025
Novartis USD 3.31B 134M Sep/2025
Philips EUR 1.31B 127M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
UCB EUR 1.29B 221M Dec/2024